ALYSSA CORRIGAN: Open Payments
NPI 1255965414 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,676 in 119 payments from 21 companies in 2025. Trend: 2023 $5,231 · 2024 $4,591 · 2025 $2,676
Food & beverage: $2,676
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $491 |
| Arcutis Biotherapeutics, Inc. | 12 | $307 |
| Janssen Biotech, Inc. | 17 | $274 |
| Amgen Inc. | 8 | $212 |
| Incyte Corporation | 8 | $184 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $165 |
| PFIZER INC. | 9 | $156 |
| Regeneron Healthcare Solutions, Inc. | 4 | $133 |
| Lilly USA, LLC | 5 | $121 |
| UCB, Inc. | 3 | $96 |
Products named: SKYRIZI, Zoryve, TREMFYA, OTEZLA, OPZELURA, RINVOQ, CIBINQO, DUPIXENT.
Industry payments across IL — which companies pay providers there.
